Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients

BACKGROUND: Graft-versus-host disease (GVHD) is a main complication following allogeneic hematopoietic stem cell transplantation and is a leading cause of non-relapse-related death. Unsatisfactory response to standard first-line therapy with glucocorticoids is a predictor of a poor prognosis in pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Cong, Zhang, Xiaoting, Liang, Dan, Yang, Jilong, Du, Jingwen, Yue, Chunyan, Deng, Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646859/
https://www.ncbi.nlm.nih.gov/pubmed/34880598
http://dx.doi.org/10.2147/DDDT.S338752

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646859/
https://www.ncbi.nlm.nih.gov/pubmed/34880598
http://dx.doi.org/10.2147/DDDT.S338752

Ejemplares similares